RS64579B1 - Nova heterociklična jedinjenja - Google Patents
Nova heterociklična jedinjenjaInfo
- Publication number
- RS64579B1 RS64579B1 RS20230788A RSP20230788A RS64579B1 RS 64579 B1 RS64579 B1 RS 64579B1 RS 20230788 A RS20230788 A RS 20230788A RS P20230788 A RSP20230788 A RS P20230788A RS 64579 B1 RS64579 B1 RS 64579B1
- Authority
- RS
- Serbia
- Prior art keywords
- heterocyclic compounds
- new heterocyclic
- new
- compounds
- heterocyclic
- Prior art date
Links
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18207725 | 2018-11-22 | ||
| PCT/EP2019/081870 WO2020104494A1 (en) | 2018-11-22 | 2019-11-20 | New heterocyclic compounds |
| EP19809026.8A EP3883936B1 (en) | 2018-11-22 | 2019-11-20 | New heterocyclic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS64579B1 true RS64579B1 (sr) | 2023-10-31 |
Family
ID=64453331
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20230788A RS64579B1 (sr) | 2018-11-22 | 2019-11-20 | Nova heterociklična jedinjenja |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US20210387999A1 (sr) |
| EP (1) | EP3883936B1 (sr) |
| JP (1) | JP7444882B2 (sr) |
| KR (1) | KR20210094540A (sr) |
| CN (1) | CN113166170A (sr) |
| AR (1) | AR117139A1 (sr) |
| AU (1) | AU2019383500A1 (sr) |
| BR (1) | BR112021009348A2 (sr) |
| CA (1) | CA3119506A1 (sr) |
| CL (1) | CL2021001330A1 (sr) |
| CO (1) | CO2021007056A2 (sr) |
| CR (1) | CR20210247A (sr) |
| DK (1) | DK3883936T3 (sr) |
| ES (1) | ES2955037T3 (sr) |
| FI (1) | FI3883936T3 (sr) |
| HR (1) | HRP20231083T1 (sr) |
| HU (1) | HUE062913T2 (sr) |
| IL (1) | IL283333B2 (sr) |
| LT (1) | LT3883936T (sr) |
| MA (1) | MA55131B1 (sr) |
| MX (1) | MX2021005714A (sr) |
| NZ (1) | NZ775640A (sr) |
| PE (1) | PE20211870A1 (sr) |
| PH (1) | PH12021551167A1 (sr) |
| PL (1) | PL3883936T3 (sr) |
| PT (1) | PT3883936T (sr) |
| RS (1) | RS64579B1 (sr) |
| SG (1) | SG11202104206SA (sr) |
| SI (1) | SI3883936T1 (sr) |
| TW (1) | TWI825227B (sr) |
| UA (1) | UA128505C2 (sr) |
| WO (1) | WO2020104494A1 (sr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR114136A1 (es) | 2017-10-10 | 2020-07-29 | Hoffmann La Roche | Compuestos heterocíclicos |
| JP7269948B2 (ja) | 2017-11-28 | 2023-05-09 | エフ． ホフマン－ラ ロシュ アーゲー | 新規複素環式化合物 |
| WO2019134985A1 (en) | 2018-01-08 | 2019-07-11 | F. Hoffmann-La Roche Ag | Octahydropyrido[1,2-alpha]pyrazines as magl inhibitors |
| UA127629C2 (uk) | 2018-08-13 | 2023-11-08 | Ф. Хоффманн-Ля Рош Аг | Нові гетероциклічні сполуки як інгібітори моноацилгліцеролліпази |
| US20210094971A1 (en) * | 2019-09-09 | 2021-04-01 | Hoffmann-La Roche Inc. | Heterocyclic compounds |
| US11814375B2 (en) | 2019-09-12 | 2023-11-14 | Hoffmann-La Roche Inc. | Heterocyclic compounds |
| BR112023003580A2 (pt) | 2020-09-03 | 2023-04-04 | Hoffmann La Roche | Compostos heterocíclicos |
| CN114195780A (zh) * | 2020-09-18 | 2022-03-18 | 上海医药集团股份有限公司 | 一种羰基杂环类化合物及其应用 |
| CN117177744A (zh) | 2021-01-29 | 2023-12-05 | 塞迪拉治疗股份有限公司 | Cdk2抑制剂及其使用方法 |
| TW202317560A (zh) | 2021-06-26 | 2023-05-01 | 美商賽迪拉治療股份有限公司 | Ｃｄｋ２抑制劑及其使用方法 |
| WO2023130050A1 (en) * | 2021-12-29 | 2023-07-06 | Psy Therapeutics, Inc. | Monoacylglycerol lipase inhibitors and use thereof for the treatment and management of pain |
| WO2023130043A1 (en) * | 2021-12-29 | 2023-07-06 | Psy Therapeutics, Inc. | Monoacylglycerol lipase inhibitors and use thereof for the treatment of anxiety |
| KR20240139073A (ko) * | 2022-01-25 | 2024-09-20 | 에프. 호프만-라 로슈 아게 | 신규 헤테로고리 화합물 |
| CN119301113A (zh) * | 2022-06-24 | 2025-01-10 | 豪夫迈·罗氏有限公司 | 作为magl抑制剂的新的杂环羰基环状化合物 |
| AU2023322411A1 (en) | 2022-08-08 | 2024-11-21 | F. Hoffmann-La Roche Ag | New heterocyclic compounds |
| WO2024033479A1 (en) * | 2022-08-11 | 2024-02-15 | Remynd N.V. | (aza)spiroheptane derivatives for the treatment of neurodegenerative disorders |
| WO2024061853A1 (en) * | 2022-09-20 | 2024-03-28 | F. Hoffmann-La Roche Ag | Fluorescent probes for magl |
| WO2024088922A1 (en) * | 2022-10-24 | 2024-05-02 | F. Hoffmann-La Roche Ag | Heterocyclic compounds as inhibitors of monoacylglycerol lipase (magl) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7579495B2 (en) | 2003-12-19 | 2009-08-25 | Momentive Performance Materials Inc. | Active-releasing cyclic siloxanes |
| EP2475667A1 (en) | 2009-09-10 | 2012-07-18 | F. Hoffmann-La Roche AG | Inhibitors of jak |
| WO2011059118A1 (ko) | 2009-11-10 | 2011-05-19 | Kim Hyun Jeen | 후각인지능력 검사 시스템 |
| JP5990297B2 (ja) | 2015-03-03 | 2016-09-14 | タイヨーエレック株式会社 | 遊技機 |
| EP3279191B1 (en) * | 2015-03-30 | 2020-09-02 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| MX2017014714A (es) | 2015-05-21 | 2018-01-25 | Glaxosmithkline Ip Dev Ltd | Derivados de benzoimidazol como inhibidores de peptidil arginina deiminasa 4 (pad4). |
| ES2823049T3 (es) | 2015-07-31 | 2021-05-05 | Pfizer | Derivados de carbamato de 1,1,1-trifluoro-3-hidroxipropan-2-ilo y derivados de carbamato de 1,1,1-trifluoro-4-hidroxibutan-2-ilo como inhibidores de MAGL |
| US10385057B2 (en) | 2015-11-20 | 2019-08-20 | Lundbeck La Jolla Research Center, Inc. | Pyrazole compounds and methods of making and using same |
| WO2021048241A1 (en) * | 2019-09-12 | 2021-03-18 | F. Hoffmann-La Roche Ag | Radiolabeled compounds |
-
2019
- 2019-11-20 CN CN201980077284.5A patent/CN113166170A/zh active Pending
- 2019-11-20 FI FIEP19809026.8T patent/FI3883936T3/fi active
- 2019-11-20 PL PL19809026.8T patent/PL3883936T3/pl unknown
- 2019-11-20 RS RS20230788A patent/RS64579B1/sr unknown
- 2019-11-20 LT LTEPPCT/EP2019/081870T patent/LT3883936T/lt unknown
- 2019-11-20 JP JP2021528972A patent/JP7444882B2/ja active Active
- 2019-11-20 KR KR1020217015287A patent/KR20210094540A/ko unknown
- 2019-11-20 AU AU2019383500A patent/AU2019383500A1/en active Pending
- 2019-11-20 PT PT198090268T patent/PT3883936T/pt unknown
- 2019-11-20 ES ES19809026T patent/ES2955037T3/es active Active
- 2019-11-20 HU HUE19809026A patent/HUE062913T2/hu unknown
- 2019-11-20 MX MX2021005714A patent/MX2021005714A/es unknown
- 2019-11-20 SG SG11202104206SA patent/SG11202104206SA/en unknown
- 2019-11-20 HR HRP20231083TT patent/HRP20231083T1/hr unknown
- 2019-11-20 WO PCT/EP2019/081870 patent/WO2020104494A1/en active Application Filing
- 2019-11-20 CR CR20210247A patent/CR20210247A/es unknown
- 2019-11-20 EP EP19809026.8A patent/EP3883936B1/en active Active
- 2019-11-20 CA CA3119506A patent/CA3119506A1/en active Pending
- 2019-11-20 BR BR112021009348-6A patent/BR112021009348A2/pt unknown
- 2019-11-20 NZ NZ775640A patent/NZ775640A/en unknown
- 2019-11-20 PE PE2021000714A patent/PE20211870A1/es unknown
- 2019-11-20 IL IL283333A patent/IL283333B2/en unknown
- 2019-11-20 DK DK19809026.8T patent/DK3883936T3/da active
- 2019-11-20 MA MA55131A patent/MA55131B1/fr unknown
- 2019-11-20 SI SI201930619T patent/SI3883936T1/sl unknown
- 2019-11-20 UA UAA202103201A patent/UA128505C2/uk unknown
- 2019-11-21 AR ARP190103417A patent/AR117139A1/es unknown
- 2019-11-21 TW TW108142267A patent/TWI825227B/zh active
-
2021
- 2021-05-20 US US17/325,934 patent/US20210387999A1/en active Pending
- 2021-05-20 CL CL2021001330A patent/CL2021001330A1/es unknown
- 2021-05-21 PH PH12021551167A patent/PH12021551167A1/en unknown
- 2021-05-28 CO CONC2021/0007056A patent/CO2021007056A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL283333A (en) | Heterocyclic compounds | |
| IL277539A (en) | The heterocyclic compounds as immunomodulators | |
| IL280821A (en) | Heterocycline compound | |
| IL289617A (en) | Heterocyclic compounds | |
| IL289595A (en) | Heterocyclic compounds | |
| ZA202104402B (en) | Heterocyclic compound | |
| IL288987A (en) | New heterocyclic compounds | |
| PT3643718T (pt) | Composto heterocíclico e seu uso como modulador alostérico positivo do recetor muscarínico colinérgico m1 | |
| EP3660003C0 (en) | HETEROCYCLIC COMPOUND | |
| SG11202009356RA (en) | Heterocyclic compound | |
| GB201810668D0 (en) | New compounds | |
| GB201811169D0 (en) | New compounds | |
| GB201810669D0 (en) | New compounds | |
| GB201915191D0 (en) | Novel heterocyclic compounds | |
| ZA201907792B (en) | Heterocyclic compound | |
| GB201806488D0 (en) | Heterocyclic TADF compounds | |
| IL277340A (en) | The orthocyclic compound | |
| GB201808580D0 (en) | Heterocyclic compounds | |
| ZA201907793B (en) | Heterocyclic compound | |
| GB201817634D0 (en) | New compounds | |
| GB201813681D0 (en) | New compounds | |
| GB201805945D0 (en) | New compounds | |
| GB201804745D0 (en) | New compounds | |
| GB201802082D0 (en) | New compounds | |
| GB201802084D0 (en) | New compounds |